Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Avantor Performance Materials, LLC maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company currently has 3 pending office actions across its active filings. These actions are distributed among 3 distinct examiners, which indicates that the prosecution workload is spread across several different individuals. Additionally, the portfolio is being reviewed within 3 distinct art units, suggesting that a variety of technical sub-specialties are involved in the company's current patent applications.
The busiest examiner for the portfolio is TRUONG, QUANGLONG N, who is currently handling 1 busiest examiner pending office action. Given that there are 3 pending office actions in total, this examiner is responsible for a portion of the active workload rather than the whole. Practitioners should note that with 3 distinct examiners and 3 distinct art units, the company must manage multiple prosecution tracks simultaneously. This distribution requires a strategy that accounts for the different perspectives and requirements of each examiner and art unit involved in the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRUONG, QUANGLONG N | 1 | 78.8% | +23.6% |
| BATES, KEENAN ALEXANDER | 1 | 45.5% | +79.5% |
| BEANE, RANDALL L | 1 | 32.8% | +36.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031517 | MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BATES, KEENAN ALEXANDER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18285918 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | TRUONG, QUANGLONG N | 117d overdue |
| 17911322 | POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING | BEANE, RANDALL L | 19d |
| 18031517 | MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BATES, KEENAN ALEXANDER | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1631 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18285918 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | TRUONG, QUANGLONG N | 1615 | — | Non-Final OA | 117d overdue | Pending | Oct 06, 2023 |
| 18031517 | MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BATES, KEENAN ALEXANDER | 1631 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2023 |
| 17911322 | POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING | BEANE, RANDALL L | 1654 | §112 | Final Rejection | 19d | Pending | Sep 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial